LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 55

Search options

  1. Article ; Online: Blastomycosis-Some Progress but Still Much to Learn.

    Pullen, Matthew F / Alpern, Jonathan D / Bahr, Nathan C

    Journal of fungi (Basel, Switzerland)

    2022  Volume 8, Issue 8

    Abstract: Blastomycosis, caused ... ...

    Abstract Blastomycosis, caused by
    Language English
    Publishing date 2022-08-07
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2784229-0
    ISSN 2309-608X ; 2309-608X
    ISSN (online) 2309-608X
    ISSN 2309-608X
    DOI 10.3390/jof8080824
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Blastomycosis—Some Progress but Still Much to Learn

    Matthew F. Pullen / Jonathan D. Alpern / Nathan C. Bahr

    Journal of Fungi, Vol 8, Iss 8, p

    2022  Volume 824

    Abstract: Blastomycosis, caused by Blastomyces spp., is an endemic mycosis capable of causing significant disease throughout the body. Higher rates of infection are seen in the Mississippi and Ohio River valleys, the Great Lakes region of the United States and ... ...

    Abstract Blastomycosis, caused by Blastomyces spp., is an endemic mycosis capable of causing significant disease throughout the body. Higher rates of infection are seen in the Mississippi and Ohio River valleys, the Great Lakes region of the United States and Canada, much of Africa, and, to a lesser extent, in India and the Middle East. Limited reporting inhibits our true understanding of the geographic distribution of blastomycosis. An estimated 50% of those infected remain asymptomatic. Of those who present with symptomatic disease, pulmonary involvement is most common, while the most common extrapulmonary sites are the skin, bones, genitourinary system, and central nervous system. Itraconazole is the standard therapy for mild–moderate disease. Data for other azoles are limited. Amphotericin is used for severe disease, and corticosteroids are occasionally used in severe disease, but evidence for this practice is limited. Despite increasing incidence and geographic reach in recent years, there are still significant knowledge gaps in our understanding of blastomycosis. Here, we provide an updated review of the epidemiology, clinical presentations, and diagnostic and therapeutic approaches for this infection. We also discuss areas needing further research.
    Keywords Blastomyces ; Blastomyces dermatitidis ; blastomycosis ; mycosis ; diseases ; fungus ; Biology (General) ; QH301-705.5
    Subject code 610
    Language English
    Publishing date 2022-08-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Patient-facing job role is associated with SARS-CoV-2 positivity among healthcare workers in long term care facilities in Minnesota, August-December, 2020.

    Bakare, R Adetunji / Mulcahy, John F / Pullen, Matthew F / Demmer, Ryan T / Cox, Sara L / Thurn, Julie A / Galdys, Alison L

    Infection control and hospital epidemiology

    2023  Volume 44, Issue 9, Page(s) 1467–1471

    Abstract: Objective: Healthcare workers (HCWs) in long-term care facilities (LTCFs) are disproportionately affected by severe acute respiratory coronavirus virus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). To characterize factors ... ...

    Abstract Objective: Healthcare workers (HCWs) in long-term care facilities (LTCFs) are disproportionately affected by severe acute respiratory coronavirus virus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). To characterize factors associated with SARS-CoV-2 positivity among LTCF HCWs, we performed a retrospective cohort study among HCWs in 32 LTCFs in the Minneapolis-St Paul region.
    Methods: We analyzed the outcome of SARS-CoV-2 polymerase chain reaction (PCR) positivity among LTCF HCWs during weeks 34-52 of 2020. LTCF and HCW-level characteristics, including facility size, facility risk score for resident-HCW contact, and resident-facing job role, were modeled in univariable and multivariable generalized linear regressions to determine their association with SARS-CoV-2 positivity.
    Results: Between weeks 34 and 52, 440 (20.7%) of 2,130 unique HCWs tested positive for SARS-CoV-2 at least once. In the univariable model, non-resident-facing HCWs had lower odds of infection (odds ratio [OR], 0.50; 95% confidence interval [CI], 0.36-0.70). In the multivariable model, the odds remained lower for non-resident-facing HCW (OR, 0.50; 95% CI, 0.36-0.71), and those in medium- versus low-risk facilities experienced higher odds of testing positive for SARS-CoV-2 (OR, 1.47; 95% CI, 1.08-2.02).
    Conclusions: Our findings suggest that COVID-19 cases are related to contact between HCW and residents in LTCFs. This association should be considered when formulating infection prevention and control policies to mitigate the spread of SARS-CoV-2 in LTCFs.
    MeSH term(s) Humans ; COVID-19/epidemiology ; COVID-19/prevention & control ; SARS-CoV-2 ; Long-Term Care ; Retrospective Studies ; Minnesota/epidemiology ; Health Personnel
    Language English
    Publishing date 2023-03-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639378-0
    ISSN 1559-6834 ; 0195-9417 ; 0899-823X
    ISSN (online) 1559-6834
    ISSN 0195-9417 ; 0899-823X
    DOI 10.1017/ice.2022.289
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: 3D RNA-scaffolded wireframe origami.

    Parsons, Molly F / Allan, Matthew F / Li, Shanshan / Shepherd, Tyson R / Ratanalert, Sakul / Zhang, Kaiming / Pullen, Krista M / Chiu, Wah / Rouskin, Silvi / Bathe, Mark

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 382

    Abstract: Hybrid RNA:DNA origami, in which a long RNA scaffold strand folds into a target nanostructure via thermal annealing with complementary DNA oligos, has only been explored to a limited extent despite its unique potential for biomedical delivery of mRNA, ... ...

    Abstract Hybrid RNA:DNA origami, in which a long RNA scaffold strand folds into a target nanostructure via thermal annealing with complementary DNA oligos, has only been explored to a limited extent despite its unique potential for biomedical delivery of mRNA, tertiary structure characterization of long RNAs, and fabrication of artificial ribozymes. Here, we investigate design principles of three-dimensional wireframe RNA-scaffolded origami rendered as polyhedra composed of dual-duplex edges. We computationally design, fabricate, and characterize tetrahedra folded from an EGFP-encoding messenger RNA and de Bruijn sequences, an octahedron folded with M13 transcript RNA, and an octahedron and pentagonal bipyramids folded with 23S ribosomal RNA, demonstrating the ability to make diverse polyhedral shapes with distinct structural and functional RNA scaffolds. We characterize secondary and tertiary structures using dimethyl sulfate mutational profiling and cryo-electron microscopy, revealing insight into both global and local, base-level structures of origami. Our top-down sequence design strategy enables the use of long RNAs as functional scaffolds for complex wireframe origami.
    MeSH term(s) Nanotechnology/methods ; RNA ; Cryoelectron Microscopy ; Nucleic Acid Conformation ; Nanostructures/chemistry ; RNA, Messenger
    Chemical Substances RNA (63231-63-0) ; RNA, Messenger
    Language English
    Publishing date 2023-01-24
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-36156-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A 66-Year-Old Man With Progressive Chest Pain, Dyspnea, and Incomplete Paraplegia of the Lower Extremities.

    Babcock, Corey P / Pullen, Matthew F / Manivel, Juan C / Yamanaka, Bradley M / Kaka, Anjum

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2020  Volume 70, Issue 12, Page(s) 2743–2746

    MeSH term(s) Aged ; Chest Pain/etiology ; Dyspnea/diagnosis ; Dyspnea/etiology ; Humans ; Lower Extremity ; Male ; Paraplegia/etiology
    Language English
    Publishing date 2020-06-09
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciz870
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: 3D RNA-scaffolded wireframe origami

    Molly F. Parsons / Matthew F. Allan / Shanshan Li / Tyson R. Shepherd / Sakul Ratanalert / Kaiming Zhang / Krista M. Pullen / Wah Chiu / Silvi Rouskin / Mark Bathe

    Nature Communications, Vol 14, Iss 1, Pp 1-

    2023  Volume 14

    Abstract: Hybrid nucleic acid origami has potential for biomedical delivery of mRNA and fabrication of artificial ribozymes. Here, the authors use chemical footprinting and cryo-electron microscopy to reveal insights into nucleic acid origami used to fold ... ...

    Abstract Hybrid nucleic acid origami has potential for biomedical delivery of mRNA and fabrication of artificial ribozymes. Here, the authors use chemical footprinting and cryo-electron microscopy to reveal insights into nucleic acid origami used to fold messenger and ribosomal RNA into 3D polyhedral structures.
    Keywords Science ; Q
    Language English
    Publishing date 2023-01-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.

    Reiersen, Angela M / Mattar, Caline / Bender Ignacio, Rachel A / Boulware, David R / Lee, Todd C / Hess, Rachel / Lankowski, Alexander J / McDonald, Emily G / Miller, J Philip / Powderly, William G / Pullen, Matthew F / Rado, Jeffrey T / Rich, Michael W / Schiffer, Joshua T / Schweiger, Julie / Spivak, Adam M / Stevens, Angela / Vigod, Simone N / Agarwal, Payal /
    Yang, Lei / Yingling, Michael / Gettinger, Torie R / Zorumski, Charles F / Lenze, Eric J

    Open forum infectious diseases

    2023  Volume 10, Issue 8, Page(s) ofad419

    Abstract: Background: Prior randomized clinical trials have reported benefit of fluvoxamine ≥200 mg/d vs placebo for patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).: Methods: This randomized, double-blind, placebo- ... ...

    Abstract Background: Prior randomized clinical trials have reported benefit of fluvoxamine ≥200 mg/d vs placebo for patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Methods: This randomized, double-blind, placebo-controlled, fully remote multisite clinical trial evaluated whether fluvoxamine prevents clinical deterioration in higher-risk outpatients with acute coronavirus disease 2019 (COVID-19). Between December 2020 and May 2021, nonhospitalized US and Canadian participants with confirmed symptomatic infection received fluvoxamine (50 mg on day 1, 100 mg twice daily thereafter) or placebo for 15 days. The primary modified intent-to-treat (mITT) population included participants who started the intervention within 7 days of symptom onset with a baseline oxygen saturation ≥92%. The primary outcome was clinical deterioration within 15 days of randomization, defined as having both (1) shortness of breath (severity ≥4 on a 0-10 scale or requiring hospitalization)
    Results: A total of 547 participants were randomized and met mITT criteria (n = 272 fluvoxamine, n = 275 placebo). The Data Safety Monitoring Board recommended stopping early for futility related to lower-than-predicted event rates and declining accrual concurrent with vaccine availability in the United States and Canada. Clinical deterioration occurred in 13 (4.8%) participants in the fluvoxamine group and 15 (5.5%) participants in the placebo group (absolute difference at day 15, 0.68%; 95% CI, -3.0% to 4.4%; log-rank
    Conclusions: This trial did not find fluvoxamine efficacious in preventing clinical deterioration in unvaccinated outpatients with symptomatic COVID-19. It was stopped early and underpowered due to low primary outcome rates.
    Clinical trials registration: ClinicalTrials.gov Identifier: NCT04668950.
    Language English
    Publishing date 2023-08-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2757767-3
    ISSN 2328-8957
    ISSN 2328-8957
    DOI 10.1093/ofid/ofad419
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Change in Plasma Cryptococcal Antigen Titer Is Not Associated With Survival Among Human Immunodeficiency Virus-infected Persons Receiving Preemptive Therapy for Asymptomatic Cryptococcal Antigenemia.

    Pullen, Matthew F / Kakooza, Francis / Nalintya, Elizabeth / Kiragga, Agnes N / Morawski, Bozena M / Rajasingham, Radha / Mubiru, Anthony / Manabe, Yukari C / Kaplan, Jonathan E / Meya, David B / Boulware, David R

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2019  Volume 70, Issue 2, Page(s) 353–355

    MeSH term(s) Antigens, Fungal ; Cryptococcus ; HIV ; Humans ; Meningitis, Cryptococcal/diagnosis ; Meningitis, Cryptococcal/drug therapy ; Plasma
    Chemical Substances Antigens, Fungal
    Language English
    Publishing date 2019-05-20
    Publishing country United States
    Document type Letter ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciz418
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments.

    Sheng, Xin / Guan, Yuting / Ma, Ziyuan / Wu, Junnan / Liu, Hongbo / Qiu, Chengxiang / Vitale, Steven / Miao, Zhen / Seasock, Matthew J / Palmer, Matthew / Shin, Myung K / Duffin, Kevin L / Pullen, Steven S / Edwards, Todd L / Hellwege, Jacklyn N / Hung, Adriana M / Li, Mingyao / Voight, Benjamin F / Coffman, Thomas M /
    Brown, Christopher D / Susztak, Katalin

    Nature genetics

    2021  Volume 53, Issue 9, Page(s) 1322–1333

    Abstract: The functional interpretation of genome-wide association studies (GWAS) is challenging due to the cell-type-dependent influences of genetic variants. Here, we generated comprehensive maps of expression quantitative trait loci (eQTLs) for 659 ... ...

    Abstract The functional interpretation of genome-wide association studies (GWAS) is challenging due to the cell-type-dependent influences of genetic variants. Here, we generated comprehensive maps of expression quantitative trait loci (eQTLs) for 659 microdissected human kidney samples and identified cell-type-eQTLs by mapping interactions between cell type abundances and genotypes. By partitioning heritability using stratified linkage disequilibrium score regression to integrate GWAS with single-cell RNA sequencing and single-nucleus assay for transposase-accessible chromatin with high-throughput sequencing data, we prioritized proximal tubules for kidney function and endothelial cells and distal tubule segments for blood pressure pathogenesis. Bayesian colocalization analysis nominated more than 200 genes for kidney function and hypertension. Our study clarifies the mechanism of commonly used antihypertensive and renal-protective drugs and identifies drug repurposing opportunities for kidney disease.
    MeSH term(s) Base Sequence ; Chromosome Mapping ; Endothelial Cells/pathology ; Genetic Predisposition to Disease/genetics ; Genome-Wide Association Study ; Genotype ; High-Throughput Nucleotide Sequencing ; Humans ; Hypertension/genetics ; Kidney Tubules, Distal/pathology ; Kidney Tubules, Proximal/pathology ; Polymorphism, Single Nucleotide/genetics ; Quantitative Trait Loci/genetics ; Quantitative Trait, Heritable ; Renal Insufficiency, Chronic/genetics ; Renal Insufficiency, Chronic/pathology ; Sequence Analysis, RNA ; Single-Cell Analysis
    Language English
    Publishing date 2021-08-12
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1108734-1
    ISSN 1546-1718 ; 1061-4036
    ISSN (online) 1546-1718
    ISSN 1061-4036
    DOI 10.1038/s41588-021-00909-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Symptoms of COVID-19 Outpatients in the United States.

    Pullen, Matthew F / Skipper, Caleb P / Hullsiek, Kathy H / Bangdiwala, Ananta S / Pastick, Katelyn A / Okafor, Elizabeth C / Lofgren, Sarah M / Rajasingham, Radha / Engen, Nicole W / Galdys, Alison / Williams, Darlisha A / Abassi, Mahsa / Boulware, David R

    Open forum infectious diseases

    2020  Volume 7, Issue 7, Page(s) ofaa271

    Abstract: Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pathogen causing the current worldwide coronavirus disease 2019 (COVID-19) pandemic. Due to insufficient diagnostic testing in the United States, there is a need for ... ...

    Abstract Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pathogen causing the current worldwide coronavirus disease 2019 (COVID-19) pandemic. Due to insufficient diagnostic testing in the United States, there is a need for clinical decision-making algorithms to guide testing prioritization.
    Methods: We recruited participants nationwide for a randomized clinical trial. We categorized participants into 3 groups: (1) those with confirmed SARS-CoV-2 infection, (2) those with probable SARS-CoV-2 infection (pending test or not tested but with a confirmed COVID-19 contact), and (3) those with possible SARS-CoV-2 infection (pending test or not tested and with a contact for whom testing was pending or not performed). We compared the frequency of self-reported symptoms in each group and categorized those reporting symptoms in early infection (0-2 days), midinfection (3-5 days), and late infection (>5 days).
    Results: Among 1252 symptomatic persons screened, 316 had confirmed, 393 had probable, and 543 had possible SARS-CoV-2 infection. In early infection, those with confirmed and probable SARS-CoV-2 infection shared similar symptom profiles, with fever most likely in confirmed cases (
    Conclusions: Symptomatic persons with probable SARS-CoV-2 infection present similarly to those with confirmed SARS-CoV-2 infection. There was no pattern of symptom frequency over time.
    Keywords covid19
    Language English
    Publishing date 2020-06-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2757767-3
    ISSN 2328-8957
    ISSN 2328-8957
    DOI 10.1093/ofid/ofaa271
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top